STANFORD, Calif.--(BUSINESS WIRE)--A national team of scientists is trying to determine if an experimental drug, called a RAGE inhibitor, can help Alzheimer’s disease patients with memory loss and other symptoms. Researchers at the Stanford University School of Medicine are among those looking for people with mild to moderate Alzheimer’s disease to participate in this phase-2 clinical trial.
